{
    "clinical_study": {
        "@rank": "163256", 
        "arm_group": [
            {
                "arm_group_label": "Controls", 
                "arm_group_type": "No Intervention", 
                "description": "Healthy pain free controls will be recruited for comparison with fibromyalgia patients."
            }, 
            {
                "arm_group_label": "Non-Traditional Acupuncture", 
                "arm_group_type": "Active Comparator", 
                "description": "40 fibromyalgia patients will be randomized to non-traditional laser acupuncture (Vita Laser 650, Lhasa OMS).  They will receive 2 treatments per week for 4 weeks."
            }, 
            {
                "arm_group_label": "Traditional Acupuncture", 
                "arm_group_type": "Active Comparator", 
                "description": "40 fibromyalgia patients will be randomized to receive electro acupuncture (AS Super 4 digital needle stimulator, Harmony Medical Co) .  They will receive 2 treatments per week for 4 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate the impact of electro-acupuncture in pain processing on\n      patients with fibromyalgia (FM). The investigators hypothesize that electro-acupuncture is\n      effective for FM because it functions as a desensitization therapy, which when applied\n      repeatedly over multiple treatment sessions, gradually habituates the nervous system to\n      continuing pain and sensory signaling."
        }, 
        "brief_title": "Neuroimaging Approaches to Deconstructing Acupuncture for Chronic Pain", 
        "completion_date": {
            "#text": "July 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Fibromyalgia", 
        "condition_browse": {
            "mesh_term": [
                "Fibromyalgia", 
                "Myofascial Pain Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study design has two components: 1) a cross sectional assessment of brain chemistry,\n      connectivity and response to pain in healthy controls and age- and sex-matched fibromyalgia\n      patients, and 2) a longitudinal assessment of the same outcomes in fibromyalgia patients\n      randomized to either electro-acupuncture or laser acupuncture.\n\n      The investigators will evaluate 80 fibromyalgia patients who will receive acupuncture\n      treatment twice a week for 4 weeks, for a total of 8 treatments.  Baseline data from these\n      patients will be compared to results from 20 pain-free controls.\n\n      Participants will undergo experimental pain assessments as well as brain neuroimaging."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for Fibromyalgia Participants\n\n          -  Met the American College of Rheumatology (1990) criteria for the diagnosis of FM [2]\n             for at least one year.\n\n          -  Continued presence of pain more than 50% of days.\n\n          -  Pain greater than 4 on a 10cm Visual Analog Scale (VAS) for pain; 7-day recall;\n             [Note: The VAS is widely used in clinical pain research and as such we chose to use\n             it for inclusion criteria and for clinical pain assessment below.  Within our group\n             numerical ratings scales 0-100 are more commonly used in quantitative sensory\n             assessment, and as such we chose to use NRS scales for evoked pain assessments\n             below.]\n\n          -  Willing to limit the introduction of any new medications or treatment modalities for\n             control of FM symptoms during the study.\n\n          -  Able to travel to the study site to receive acupuncture treatments up to two times\n             weekly.\n\n          -  Over 18 and under 65 years of age.\n\n          -  Right-handed.\n\n          -  Female.\n\n          -  Capable of giving written informed consent.\n\n        Inclusion Criteria for Healthy Control Participants\n\n          -  Over 18 and under 65 years of age.\n\n          -  Female.\n\n          -  Right-handed.\n\n          -  Pain less than 4 on a 10cm Visual Analog Scale (VAS) for pain; 7-day recall\n\n          -  Willing to complete all study procedures.\n\n          -  Capable of giving written informed consent.\n\n        Exclusion Criteria for Fibromyalgia Participants:\n\n          -  Acupuncture within last 6-months.\n\n          -  Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis\n             that may preclude the safe use of acupuncture.\n\n          -  Presence of a concurrent autoimmune or inflammatory disease such as rheumatoid\n             arthritis, systemic lupus erythematosus, inflammatory bowel disease, etc. that causes\n             pain.\n\n          -  Routine daily use of narcotic analgesics or history of substance abuse.\n\n          -  Stimulant medications, such as those used to treat ADD/ADHD (e.g., amphetamine/\n             dextroamphetamine [Adderall\u00ae], methylphenidate, dextroamphetamine), or the fatigue\n             associated with sleep apnea or shift work (e.g., modafinil), are excluded.\n\n          -  Concurrent participation in other therapeutic trials.\n\n          -  Pregnant or nursing.\n\n          -  Severe psychiatric illnesses (current schizophrenia, major depression with suicidal\n             ideation, substance abuse within two years).\n\n          -  Contraindications to fcMRI, fMRI, or 1H-MRS methods.  These may include but are not\n             limited to: surgical clips, surgical staples, metal implants, and certain metallic\n             dental material. [Note: a more formal description of contraindications for MRI is\n             present in our DSM Plan].\n\n          -  Any impairment, activity or situation that in the judgment of the Study Coordinator\n             or Principal Investigator that would prevent satisfactory completion of the study\n             protocol. This includes unreliable, or inconsistent pain scores as deemed by the\n             principal investigator.\n\n        Exclusion Criteria for Healthy Control Participants:\n\n          -  Have met the American College of Rheumatology (1990) criteria for the diagnosis of\n             FM.\n\n          -  Presence of a concurrent autoimmune or inflammatory disease such as rheumatoid\n             arthritis, systemic lupus erythematosus, inflammatory bowel disease, etc. that causes\n             pain.\n\n          -  Routine daily use of narcotic analgesics or history of substance abuse.\n\n          -  Stimulant medications, such as those used to treat ADD/ADHD (e.g., amphetamine/\n             dextroamphetamine [Adderall\u00ae], methylphenidate, dextroamphetamine), or the fatigue\n             associated with sleep apnea or shift work (e.g., modafinil), are excluded.\n\n          -  Concurrent participation in other therapeutic trials.\n\n          -  Pregnant or nursing.\n\n          -  Severe psychiatric illnesses (current schizophrenia, major depression with suicidal\n             ideation, substance abuse within two years).\n\n          -  Contraindications to fcMRI, fMRI, or 1H-MRS methods. (see above section)\n\n          -  Any impairment, activity or situation that in the judgment of the Study Coordinator\n             or Principal Investigator that would prevent satisfactory completion of the study\n             protocol."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064296", 
            "org_study_id": "AcuAfference", 
            "secondary_id": "R01AT007550"
        }, 
        "intervention": [
            {
                "arm_group_label": "Traditional Acupuncture", 
                "description": "This group will receive needle acupuncture at 3 pairs of sites. The needles will be stimulated with low intensity, low frequency electric current using a constant-current electro-acupuncture device.", 
                "intervention_name": "Needle acupuncture (Traditional Acupuncture)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Non-Traditional Acupuncture", 
                "description": "For non-traditional acupuncture, a laser acupuncture device will be positioned over all of the same acupoints used in EA. There will be no palpation prior to positioning these devices, and there will be no physical contact between device and skin.", 
                "intervention_name": "Laser acupuncture (Non-traditional Acupuncture)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Fibromyalgia Chronic Pain", 
        "lastchanged_date": "February 14, 2014", 
        "location": {
            "contact": {
                "email": "acuafference@umich.edu", 
                "last_name": "CPFRC", 
                "phone": "866-288-0046"
            }, 
            "facility": {
                "address": {
                    "city": "Ann Arbor", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48106"
                }, 
                "name": "Chronic Pain and Fatigue Research Center"
            }, 
            "investigator": [
                {
                    "last_name": "Richard E Harris, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Steve E Harte, phD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bradly Foerster, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alex Tsodikov, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Daniel J Clauw, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Neuroimaging Approaches to Deconstructing Acupuncture for Chronic Pain", 
        "overall_contact": {
            "email": "acuafference@umich.edu", 
            "last_name": "U-M CPFRC", 
            "phone": "1-866-288-0046"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Michigan", 
                "last_name": "Richard E Harris, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Massachusetts General Hospital", 
                "last_name": "Viataly Napadow, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Characterize the altered somatosensory-related neurocircuitry underlying chronic pain in FM.", 
                "measure": "Neurocircuitry underlying chronic pain", 
                "safety_issue": "No", 
                "time_frame": "At baseline"
            }, 
            {
                "description": "Brain neurochemistry and connectivity will be assessed at baseline and following either electroacupuncture or laser acupuncture.", 
                "measure": "Change in brain connectivity and neurochemistry with acupuncture treatment", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064296"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Michigan", 
            "investigator_full_name": "Richard Harris", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Baseline neuroimaging outcomes of connectivity and neurochemistry will be used to predict subsequent response to electroacupuncture and laser acupuncture.", 
            "measure": "Predicting response to acupuncture", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "University of Michigan", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Center for Complementary and Alternative Medicine (NCCAM)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Massachusetts General Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Michigan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}